Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DLO NYSE:HIMS NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$14.48-0.8%$12.84$9.81▼$16.78$4.30B0.973.08 million shs1.95 million shsHIMSHims & Hers Health$32.89-2.3%$30.14$13.74▼$70.43$7.80B2.3513.17 million shs9.88 million shsTEMTempus AI$52.47-2.1%$51.60$41.73▼$104.32$9.62B3.465.12 million shs3.89 million shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal-0.75%-4.67%+13.66%+5.85%+29.40%HIMSHims & Hers Health-2.20%-4.53%+2.88%+14.45%-36.45%TEMTempus AI-2.09%-9.89%+7.54%-6.09%-12.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDLODLocal$14.48-0.8%$12.84$9.81▼$16.78$4.30B0.973.08 million shs1.95 million shsHIMSHims & Hers Health$32.89-2.3%$30.14$13.74▼$70.43$7.80B2.3513.17 million shs9.88 million shsTEMTempus AI$52.47-2.1%$51.60$41.73▼$104.32$9.62B3.465.12 million shs3.89 million shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDLODLocal-0.75%-4.67%+13.66%+5.85%+29.40%HIMSHims & Hers Health-2.20%-4.53%+2.88%+14.45%-36.45%TEMTempus AI-2.09%-9.89%+7.54%-6.09%-12.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDLODLocal 3.00Buy$17.2519.13% UpsideHIMSHims & Hers Health 2.19Hold$30.70-6.66% DownsideTEMTempus AI 2.47Hold$68.9231.36% UpsideCurrent Analyst Ratings BreakdownLatest HIMS, DLO, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2026TEMTempus AI GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$60.00 ➝ $65.007/15/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/13/2026HIMSHims & Hers Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold7/9/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$36.00 ➝ $37.007/1/2026HIMSHims & Hers Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$32.00 ➝ $40.007/1/2026DLODLocal UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$16.00 ➝ $20.007/1/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$25.00 ➝ $36.006/30/2026TEMTempus AI Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold6/17/2026TEMTempus AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/17/2026HIMSHims & Hers Health BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$29.00 ➝ $39.006/8/2026HIMSHims & Hers Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell(Data available from 7/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDLODLocal$1.09B3.91$0.91 per share15.97$1.93 per share7.50HIMSHims & Hers Health$2.35B3.24$0.82 per share40.24$2.38 per share13.82TEMTempus AI$1.27B7.41N/AN/A$2.76 per share19.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDLODLocal$196.80M$0.6322.9813.53N/A15.85%41.22%14.27%8/13/2026 (Estimated)HIMSHims & Hers Health$128.37M-$0.09N/A63.2594.78-0.56%6.10%1.52%8/10/2026 (Estimated)TEMTempus AI-$245.03M-$1.72N/AN/AN/A-22.20%-53.83%-11.17%7/30/2026 (Confirmed)Latest HIMS, DLO, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2026Q2 2026DLODLocal$0.20N/AN/AN/A$364.96 millionN/A8/10/2026Q2 2026HIMSHims & Hers Health-$0.07N/AN/AN/A$691.65 millionN/A7/30/2026Q2 2026TEMTempus AI-$0.13N/AN/AN/A$379.54 millionN/A5/14/2026Q1 2026DLODLocal$0.16$0.17+$0.01$0.14$331.20 million$335.86 million5/11/2026Q1 2026HIMSHims & Hers Health$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million5/5/2026Q1 2026TEMTempus AI-$0.21-$0.13+$0.08-$0.71$345.44 million$348.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDLODLocal$0.795.46%N/A125.40%N/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDLODLocalN/A1.331.33HIMSHims & Hers Health2.181.691.56TEMTempus AI2.963.313.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDLODLocal90.13%HIMSHims & Hers Health63.52%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipDLODLocal45.44%HIMSHims & Hers Health11.76%TEMTempus AI24.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDLODLocal1,274294.93 million160.92 millionOptionableHIMSHims & Hers Health2,442231.46 million204.24 millionOptionableTEMTempus AI3,800179.57 million136.00 millionN/AHIMS, DLO, and TEM HeadlinesRecent News About These CompaniesTempus AI delivered on Q1 2026, but the momentum question remainsJuly 17 at 8:00 AM | msn.comTempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health ServiceJuly 16 at 9:00 AM | businesswire.comCanal Insurance CO Acquires 20,000 Shares of Tempus AI, Inc. $TEMJuly 14, 2026 | marketbeat.comBest Artificial Intelligence Stocks To Add to Your Watchlist - July 13thJuly 14, 2026 | americanbankingnews.comTempus AI: Building Ultimate Healthcare Data DominanceJuly 13, 2026 | seekingalpha.comSqueeze Watch: 10 Stocks Bears Love to Hate Most Right NowJuly 13, 2026 | benzinga.comTempus AI: The Market Is Betting On An Inflection I Can't Yet SeeJuly 13, 2026 | seekingalpha.comDiversify Wealth Management LLC Raises Stock Position in Tempus AI, Inc. $TEMJuly 13, 2026 | marketbeat.comMorgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM)July 11, 2026 | theglobeandmail.comTempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 33,284 SharesJuly 11, 2026 | insidertrades.comLaw Offices of Frank R. Cruz Encourages Tempus AI, Inc. (TEM) Investors To Inquire About Securities Fraud Class ActionJuly 10, 2026 | businesswire.comInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,910,168.76 in StockJuly 10, 2026 | marketbeat.comSumitomo Mitsui Trust Group Inc. Raises Position in Tempus AI, Inc. $TEMJuly 10, 2026 | marketbeat.comTempus to Report Second Quarter 2026 Financial Results on July 30July 9, 2026 | finance.yahoo.comInsider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 10,000 Shares of StockJuly 9, 2026 | insidertrades.comArtificial Intelligence Stocks To Add to Your Watchlist - July 8thJuly 9, 2026 | americanbankingnews.comFreedom Capital Initiates Coverage of Tempus AI, Inc. (TEM)July 8, 2026 | insidermonkey.comTempus AI, Inc. $TEM Shares Bought by Janney Montgomery Scott LLCJuly 8, 2026 | marketbeat.comTempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology ResearchJuly 6, 2026 | finance.yahoo.comTempus AI (TEM) Leverages AI for Precision Medicine AdvancementsJuly 5, 2026 | finance.yahoo.comLeonteq Securities AG Buys 29,116 Shares of Tempus AI, Inc. $TEMJuly 4, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThese 3 Bitcoin Miner Stocks Are Riding the AI Data Center BoomBy Dan Schmidt | June 22, 2026As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the WinnerBy Jessica Mitacek | July 6, 20263 Dividend Stocks with Growth on Tap for the Second HalfBy Chris Markoch | July 13, 2026CleanSpark Inks a $6.6B AI Lease to Become a Digital LandlordBy Jeffrey Neal Johnson | July 15, 2026AI Is Selling Off, But These 5 Stocks Could Benefit NextBy Ryan Hasson | July 6, 2026HIMS, DLO, and TEM Company DescriptionsDLocal NASDAQ:DLO$14.48 -0.11 (-0.75%) Closing price 07/17/2026 04:00 PM EasternExtended Trading$14.53 +0.05 (+0.35%) As of 07/17/2026 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.DLocal Limited operates a payment processing platform worldwide. The company offers pay-in solution which the business and get paid for their products and services through various payment methods, including international and local cards, online bank transfers and direct debit, cash, and alternative payment methods. It also provides pay-out solution used for merchants to scale pay-out operations. In addition, the company offers dLocal for Platforms, an end-to-end payment solution that offers a range of services to help platforms manage payments. It serves its products to commerce, streaming, ride-hailing, financial services, advertising, SaaS, travel, e-learning, on-demand delivery, and gaming and crypto industries. DLocal Limited was founded in 2016 and is headquartered in Montevideo, Uruguay.Hims & Hers Health NYSE:HIMS$32.89 -0.79 (-2.35%) Closing price 07/17/2026 03:59 PM EasternExtended Trading$32.77 -0.12 (-0.37%) As of 07/17/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Tempus AI NASDAQ:TEM$52.47 -1.12 (-2.09%) Closing price 07/17/2026 04:00 PM EasternExtended Trading$52.45 -0.02 (-0.03%) As of 07/17/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector GE Aerospace Faces a Prove-It Moment in Q2 Earnings Sandisk: What the Chart Is Trying to Tell Us Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Has Broadcom Become Too Expensive for Its AI Story? 3 Picks-and-Shovels Stocks Powering the Humanoid Robotics Buildout Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
